Sex and species differences in plasma oxytocin using an enzyme immunoassay
Kristin M. Kramer, Mary Ann Ottinger(University of Houston), Bruce S. Cushing, Julie M. Wu(National Institutes of Health), C Sue Carter
Cited by 101
Related Papers
Adverse Outcome Pathway (AOP) Development I: Strategies and Principles
|Toxicological Sciences|2014|725
Aging in Rhesus Monkeys: Relevance to Human Health Interventions
|Science|2004|363
GLP-1 Receptor Stimulation Reduces Amyloid-β Peptide Accumulation and Cytotoxicity in Cellular and Animal Models of Alzheimer's Disease
|Journal of Alzheimer s Disease|2010|325
Adverse Outcome Pathway Development II: Best Practices
|Toxicological Sciences|2014|261
Sex steroid levels in developing and adult male and female zebra finches (Poephila guttata)
|General and Comparative Endocrinology|1990|238